TruScreen Announces Share Purchase Plan Details
Company Announcement 14 September 2018
TRUSCREEN ANNOUNCES SHARE PURCHASE PLAN DETAILS
Cervical cancer technology company, TruScreen Limited (NZAX:TRU), has today announced the
details of the Share Purchase Plan (SPP) previously advised, with eligible shareholders invited to
subscribe for up to $15,000 of new shares at 21 cents per share, the same pricing as the recent
Placement on 6 September 2018.
The Share Purchase Plan is the second stage of the capital raising announced on 31 August 2018 and
follows the successful $1.5 million Placement to existing and new investors.
TruScreen is seeking to raise up to $1.0 million from this SPP. (The maximum amount legally able to
be raised under NZAX Rule 7.3.4 (c) is $13,188,765).
The SPP opens on Monday 17 September and the Record Date for the SPP offer is 5pm, Friday 14
September 2018. The Offer will close on 3 October 2018.
The funds raised from the placement and SPP will be used to strengthen TruScreen’s balance sheet,
fund sales and marketing initiatives, expand manufacturing capabilities and continue improvement
to the device’s performance.
Chairman of TruScreen, Mr Robert Hunter, said: “The development of our second generation
TruScreen device has opened up a number of new and significant opportunities and the capital
raised will help us realise these and progress with our commercial strategy. The capital raising has
been structured to provide existing shareholders the same opportunity to participate and share in
the growth of our company as investors in the Placement.”
A copy of the Appendix 4 Notice required under the NZAX Listing Rules accompanies this
announcement.
Key Dates
Record Date for participation in the SPP 5pm on 14 September 2018
Mailing of SPP and Forms to eligible shareholders 17 September 2018
Offer Period 17 September 2018 to 3 October 2018
Allotment Date On or before 10 October 2018
ENDS
For more information visit www.truscreen.com or contact Martin Dillon, TruScreen Chief Executive
Officer, email: martindillon@truscreen.com.
For media assistance, please contact: Jackie Ellis on 64 27 246 2505 or email jackie@ellisandco.co.nz.
About TruScreen:
TruScreen’s real time cervical cancer
technology utilises a digital wand which is
placed on the surface of the cervix to measure
electrical and optical signals from the
surrounding tissue. A sophisticated proprietary
algorithm framework distinguishes between
normal and abnormal (cancerous and
precancerous) tissue to identify precancerous
change, or cervical intraepithelial neoplasia
(CIN). A Single Use Sensor (SUS) is used for
each patient to protect against cross-infection.
---
APPENDIX 4 – NZAX Listing Rules
Number of pages including this one
(Please provide any other relevant
NZAX Listing Rule 7.11.2. For rights, NZAX Listing Rules 7.9.8 and 7.9.9. details on additional pages)
For change to allotment, NZAX Listing Rule 7.10.1, a separate advice is required.
Full name
of Issuer
Name of officer authorised to
Authority for event,
make this notice
e.g. Directors' resolution
Contact phone
Contact fax
numbernumber
Date
Nature of event
BonusIf ticked,
Rights Issue
Tick as appropriate
Issue
state whether:Taxable
/ Non TaxableConversionInterestRenouncable
Share purchase planRights IssueCapitalCallDividend
If ticked, stateFull
non-renouncable
change
X
whether:
InterimYearSpecialDRP Applies
EXISTING securities affected by this
If more than one security is affected by the event, use a separate form.
Description of theISIN
class of securities
If unknown, contact NZX
Details of securities issued pursuant to this eventIf more than one class of security is to be issued, use a separate form for each class.
Description of theISIN
class of securities
If unknown, contact NZX
Number of Securities toMinimum
Ratio, e.g.
be issued following eventEntitlement
1 for 2 for
Conversion, Maturity, Call
Treatment of Fractions
Payable or Exercise Date
Tick if
provide an
pari passu
ORexplanation
Strike price per security for any issue in lieu or date
of the
Strike Price available.
ranking
Monies Associated with Event
Dividend payable, Call payable, Exercise price, Conversion price, Redemption price, Application money.
Source of
Amount per security
Payment
(does not include any excluded income)
Excluded income per security
(only applicable to listed PIEs)
Supplementary
Amount per security
Currencydividendin dollars and cents
details -
NZAX Listing Rule 7.11.4
Total monies
TaxationAmount per Security in Dollars and cents to six decimal places
In the case of a taxable bonusResident
Imputation Credits
issue state strike priceWithholding Tax(Give details)
Foreign
FDP Credits
Withholding Tax(Give details)
Timing
(Refer Appendix 5 in the NZAX Listing Rules)
Record Date 5pmApplication Date
For calculation of entitlements -Also, Call Payable, Dividend /
Interest Payable, Exercise Date,
Conversion Date. In the case
of applications this must be the
last business day of the week.
Notice DateAllotment Date
Entitlement letters, call notices,For the issue of new securities.
conversion notices mailedMust be within 5 business days
of application closing date.
OFFICE USE ONLY
Ex Date:
Commence Quoting Rights:Security Code:
Cease Quoting Rights 5pm:
Commence Quoting New Securities:Security Code:
Cease Quoting Old Security 5pm:
14 September, 20183 October, 2018
10 October, 201817 September, 2018
$$
$
Date Payable
N/AN/A
Enter N/A if not
applicable
New shares issued under the SPP will rank equally with all
existing shares on issue in the Company
Ordinary shares to be issued under Share Purchase Plan
In dollars and cents
21 cents
+61 449 115 065n/a14092018
To be determined once acceptances are
received
N/AN/A
Ordinary fully paid shares
EMAIL: announce@nzx.com
Notice of event affecting securities
Truscreen Limited
Martin DillonDirectors resolution
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.